{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:23:33Z","timestamp":1790083413016,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejca.2024.115109","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T13:25:50Z","timestamp":1730553950000},"page":"115109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial"],"prefix":"10.1016","volume":"213","author":[{"given":"Lingyun","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechang","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shundong","family":"Cang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun\u2019en","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Cytryn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun J.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejca.2024.115109_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.ejca.2024.115109_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3322\/caac.21601","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"64","key":"10.1016\/j.ejca.2024.115109_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23640","article-title":"3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT","volume":"23","author":"Iveson","year":"2019","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.ejca.2024.115109_bib4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.20.01330","article-title":"Duration of adjuvant doublet chemotherapy (3 or 6 months) in patients with high-risk stage II colorectal cancer","volume":"39","author":"Iveson","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2024.115109_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jamaoncol.2019.6486","article-title":"Assessment of duration and effects of 3 vs 6 months of adjuvant chemotherapy in high-risk stage II colorectal cancer: a subgroup analysis of the TOSCA randomized clinical trial","volume":"6","author":"Petrelli","year":"2020","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2024.115109_bib6","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.clcc.2020.05.005","article-title":"Eligibility of real-world patients with stage II and III colon cancer for adjuvant chemotherapy trials","volume":"19","author":"Batra","year":"2020","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ejca.2024.115109_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jss.2020.02.016","article-title":"Receipt of adjuvant chemotherapy in stage II colon cancer and overall survival: a national cancer database study","volume":"252","author":"Enofe","year":"2020","journal-title":"J Surg Res"},{"issue":"3","key":"10.1016\/j.ejca.2024.115109_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.3587","article-title":"Association of a shortened duration of adjuvant chemotherapy with overall survival among individuals with stage III colon cancer","volume":"4","author":"Boyne","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.ejca.2024.115109_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.4154","article-title":"Association between adjuvant chemotherapy duration and survival among patients with stage II and III colon cancer: a systematic review and meta-analysis","volume":"2","author":"Boyne","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.ejca.2024.115109_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12885-018-4309-6","article-title":"Influence of complete administration of adjuvant chemotherapy cycles on overall and disease-free survival in locally advanced rectal cancer: post hoc analysis of a randomized, multicenter, non-inferiority, phase 3 trial","volume":"18","author":"Sandra-Petrescu","year":"2018","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2024.115109_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ijc.33806","article-title":"Survival outcomes associated with completion of adjuvant oxaliplatin-based chemotherapy for stage III colon cancer: A national population-based study","volume":"150","author":"Boyle","year":"2022","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2024.115109_bib12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s12032-010-9644-7","article-title":"Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer","volume":"28","author":"Hu","year":"2011","journal-title":"Med Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2024.115109_bib13","article-title":"Patients' preferences for 3 months vs 6 months of adjuvant chemotherapy for colon cancer","volume":"5","author":"Blinman","year":"2021","journal-title":"JNCI Cancer Spectr"},{"issue":"12","key":"10.1016\/j.ejca.2024.115109_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122963","article-title":"Triplet chemotherapy with cisplatin versus oxaliplatin in the CRITICS trial: treatment compliance, toxicity, outcomes and quality of life in patients with resectable gastric cancer","volume":"14","author":"Slagter","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ejca.2024.115109_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jgo.2018.01.009","article-title":"Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr study","volume":"9","author":"Rosati","year":"2018","journal-title":"J Geriatr Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2024.115109_bib16","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/cncr.33324","article-title":"Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancer","volume":"127","author":"Lee","year":"2021","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2024.115109_bib17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1089\/acm.2011.0327","article-title":"Integrating complementary medicine and supportive care: patients' perspectives toward complementary medicine and spirituality","volume":"18","author":"Ben-Arye","year":"2012","journal-title":"J Alter Complement Med"},{"issue":"3","key":"10.1016\/j.ejca.2024.115109_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/ajco.12490","article-title":"Complementary and alternative medicine use by patients receiving curative-intent chemotherapy","volume":"12","author":"Smith","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.ejca.2024.115109_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fnut.2019.00196","article-title":"Biologically-based complementary and alternative medicine (CAM) use in cancer patients: the good, the bad, the misunderstood","volume":"6","author":"Knecht","year":"2019","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.ejca.2024.115109_bib20","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1038\/s41598-019-41532-3","article-title":"Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre","volume":"9","author":"Jermini","year":"2019","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ejca.2024.115109_bib21","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jamaoncol.2016.0685","article-title":"Association between complementary and alternative medicine use and breast cancer chemotherapy initiation: the breast cancer quality of care (BQUAL) study","volume":"2","author":"Greenlee","year":"2016","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2024.115109_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1200\/JGO.2016.007955","article-title":"Do perceived needs affect willingness to use traditional chinese medicine for survivorship care among Chinese cancer survivors? A cross-sectional survey","volume":"3","author":"Sun","year":"2017","journal-title":"J Glob Oncol"},{"issue":"21","key":"10.1016\/j.ejca.2024.115109_bib23","first-page":"1","article-title":"Guidelines for traditional Chinese medicine intervention with western medicine conventional\u00a0treatment for stage I-III colorectal cancer","volume":"29","author":"Bin","year":"2023","journal-title":"Chin J Exp Tradit Med Formul"},{"issue":"11","key":"10.1016\/j.ejca.2024.115109_bib24","first-page":"1493","article-title":"Development and application strategies of traditional Chinese medicine clinical practice guidelines for colorectal cancer","volume":"18","author":"Yufei","year":"2023","journal-title":"World Tradit Chin Med"},{"issue":"02","key":"10.1016\/j.ejca.2024.115109_bib25","first-page":"125","article-title":"A preliminary discussion on the sequential spleen tonifying and kidney tonifying(Jianpi Bushen) treatments combined with chemotherapy based on \"benefiting the weak organ\u201d theory","author":"Yufei","year":"2021","journal-title":"J Tradit Chin Med"},{"issue":"10","key":"10.1016\/j.ejca.2024.115109_bib26","first-page":"3640","article-title":"The application of \"two-stage trilogy\" in adjuvant chemotherapy for colorectal cancer","author":"Shaohua","year":"2020","journal-title":"World Sci Technol - Mod Tradit Chin Med"},{"key":"10.1016\/j.ejca.2024.115109_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.876781","article-title":"Liujunanwei decoction attenuates cisplatin-induced nausea and vomiting in a Rat-Pica model partially mediated by modulating the gut micsrobiome","volume":"12","author":"Chen","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"10.1016\/j.ejca.2024.115109_bib28","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s11655-021-3448-9","article-title":"Effect of Jianpi Bushen sequential formula on adjuvant chemotherapy of colon cancer: study protocol for a randomized controlled trial","volume":"27","author":"Zhang","year":"2021","journal-title":"Chin J Integr Med"},{"issue":"7","key":"10.1016\/j.ejca.2024.115109_bib29","first-page":"656","article-title":"Exploration into the preparation of placebos used in Chinese medicinal clinical trial","volume":"29","author":"Tang","year":"2009","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"1","key":"10.1016\/j.ejca.2024.115109_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12906-019-2722-2","article-title":"Placebo design in WHO-registered trials of Chinese herbal medicine need improvements","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Complement Alter Med"},{"issue":"2","key":"10.1016\/j.ejca.2024.115109_bib31","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/j.clcc.2021.09.008","article-title":"Impact of relative dose intensity of FOLFOX adjuvant chemotherapy on risk of death among stage III colon cancer patients","volume":"21","author":"Zhou","year":"2022","journal-title":"Clin Colorectal Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2024.115109_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12885-021-08183-y","article-title":"Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study","volume":"21","author":"\u017bok","year":"2021","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2024.115109_bib33","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.3390\/curroncol28050342","article-title":"The influence of adjuvant chemotherapy dose intensity on five-year outcomes in resected colon cancer: a single centre retrospective analysis","volume":"28","author":"Lakkunarajah","year":"2021","journal-title":"Curr Oncol"},{"issue":"15","key":"10.1016\/j.ejca.2024.115109_bib34","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1200\/JCO.2017.76.0355","article-title":"Three versus 6 months of oxaliplatin-based adjuvant chemotherapy for patients with stage III colon cancer: disease-free survival results from a randomized, open-label, international duration evaluation of adjuvant (IDEA) France, Phase III Trial","volume":"36","author":"Andr\u00e9","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2024.115109_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00520-023-08221-4","article-title":"2023 updated MASCC\/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents","volume":"32","author":"Herrstedt","year":"2023","journal-title":"Support Care Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2024.115109_bib36","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1007\/s12325-020-01419-6","article-title":"Patient burden and real-world management of chemotherapy-induced myelosuppression: results from an online survey of patients with solid tumors","volume":"37","author":"Epstein","year":"2020","journal-title":"Adv Ther"},{"issue":"17","key":"10.1016\/j.ejca.2024.115109_bib37","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1200\/JCO.2014.59.1081","article-title":"Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial","volume":"33","author":"van Waart","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2024.115109_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35204","article-title":"Effect of home-based resistance training on chemotherapy relative dose intensity and tolerability in colon cancer: The FORCE randomized control trial","author":"Caan","year":"2024","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.ejca.2024.115109_bib39","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/cncr.29173","article-title":"Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey","volume":"121","author":"Bauml","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2024.115109_bib40","article-title":"Therapeutic effect and mechanism of Bushen-Jianpi-Jiedu decoction combined with chemotherapeutic drugs on postoperative colorectal cancer","volume":"12","author":"Yang","year":"2021","journal-title":"Front Pharm"},{"key":"10.1016\/j.ejca.2024.115109_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02648725.2023.2178970","article-title":"Study on the effect of Jianpi Yiqi decoction on clinical symptoms, inflammation, oxidative stress, efficacy and adverse reactions in sufferers with colorectal cancer","author":"Yang","year":"2023","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"32","key":"10.1016\/j.ejca.2024.115109_bib42","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.12998\/wjcc.v9.i32.9869","article-title":"Efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation","volume":"9","author":"Li","year":"2021","journal-title":"World J Clin Cases"},{"issue":"11","key":"10.1016\/j.ejca.2024.115109_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078709","article-title":"Differences in survival between colon and rectal cancer from SEER data","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2024.115109_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/jso.27754","article-title":"Heterogeneity in survival within age groups of early-onset colorectal cancer patients: A National Cancer Database analysis","author":"Ray-Offor","year":"2024","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2024.115109_bib45","first-page":"JCO2400394","article-title":"Assessment of the addition of oxaliplatin to fluoropyrimidine-based adjuvant chemotherapy in patients with high-risk stage II colon cancer: an ACCENT pooled analysis","author":"Chibaudel","year":"2024","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2024.115109_bib46","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1200\/JCO.2004.05.063","article-title":"American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer","volume":"22","author":"Benson","year":"2004","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2024.115109_bib47","article-title":"Does adjuvant chemotherapy benefit patients with T4 N0 colon cancer?","volume":"60","author":"Akdag","year":"2024","journal-title":"Med (Kaunas)"},{"key":"10.1016\/j.ejca.2024.115109_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.clcc.2024.05.005","article-title":"Survival outcomes in patients with monobloc-resected stage IIC (pT4bN0) colon cancer: a retrospective observational cohort study","author":"Logeart","year":"2024","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ejca.2024.115109_bib49","doi-asserted-by":"crossref","first-page":"OP2400159","DOI":"10.1200\/OP.24.00159","article-title":"Risk without reward: differing patterns of chemotherapy use do not improve outcomes in stage II early-onset colon cancer","author":"Leary","year":"2024","journal-title":"JCO Oncol Pr"},{"issue":"6","key":"10.1016\/j.ejca.2024.115109_bib50","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4251\/wjgo.v12.i6.604","article-title":"Real-world evidence on adjuvant chemotherapy in older adults with stage II\/III colon cancer","volume":"12","author":"Batra","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.ejca.2024.115109_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241266164","article-title":"Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer","volume":"16","author":"Kramer","year":"2024","journal-title":"Ther Adv Med Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2024.115109_bib52","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cam4.745","article-title":"Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data","volume":"5","author":"Amlani","year":"2016","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.ejca.2024.115109_bib53","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1177\/00031348211054708","article-title":"Clinical and socioeconomic factors that predict non-completion of adjuvant chemotherapy for colorectal cancer in a rural cancer center","volume":"89","author":"Knotts","year":"2023","journal-title":"Am Surg"},{"issue":"4","key":"10.1016\/j.ejca.2024.115109_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041423","article-title":"The impact of pre-chemotherapy body composition and immunonutritional markers on chemotherapy adherence in stage iii colorectal cancer patients","volume":"12","author":"Lee","year":"2023","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.ejca.2024.115109_bib55","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/cam4.2843","article-title":"Prognostic factors of adjuvant chemotherapy discontinuation among stage III colon cancer patients: A survey of medical oncologists and a systematic review and meta-analysis","volume":"9","author":"Boyne","year":"2020","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.ejca.2024.115109_bib56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jgo.2015.02.001","article-title":"Deciding on adjuvant chemotherapy for elderly patients with stage III colon cancer: a qualitative insight into the perspectives of surgeons and medical oncologists","volume":"6","author":"van Erning","year":"2015","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.ejca.2024.115109_bib57","article-title":"Network pharmacology and experimental verification-based strategy to explore the underlying mechanism of Liu Jun An Wei formula in the treatment of gastrointestinal reactions caused by chemotherapy for colorectal cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharm"},{"key":"10.1016\/j.ejca.2024.115109_bib58","series-title":"The Effectiveness and Mechanism of Tonifying Kidney and Spleen Method on Preventing and Treatment of Myelosuppression Induced by Adjuvant Chemotherapy of Colorectal Cancer","author":"Shaohua","year":"2021"},{"key":"10.1016\/j.ejca.2024.115109_bib59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4236\/cm.2024.152003","article-title":"The essential role of Zheng Qi in promoting health: from the perspective of chinese medicine and modern\u00a0medicine","volume":"15","author":"Ko","year":"2024","journal-title":"Chin Med"},{"key":"10.1016\/j.ejca.2024.115109_bib60","series-title":"Clinial study and mechanism of Jianpi Bushen prescription in alleviating adverse reactions of adjuvant chemotherapy for colon cancer","author":"Zhao","year":"2022"},{"issue":"3","key":"10.1016\/j.ejca.2024.115109_bib61","article-title":"Role of pyroptosis in the pathogenesis and treatment of diseases","volume":"4","author":"Jin","year":"2023","journal-title":"MedComm (2020)"},{"issue":"11","key":"10.1016\/j.ejca.2024.115109_bib62","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.12998\/wjcc.v11.i11.2386","article-title":"Pyroptosis and its role in cancer","volume":"11","author":"Liu","year":"2023","journal-title":"World J Clin Cases"},{"issue":"8","key":"10.1016\/j.ejca.2024.115109_bib64","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11655-016-2538-6","article-title":"A preparation model of Chinese medicine decoction placebo","volume":"23","author":"Bian","year":"2017","journal-title":"Chin J Integr Med"},{"issue":"3","key":"10.1016\/j.ejca.2024.115109_bib65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3747\/co.27.6529","article-title":"Impact of the COVID-19 outbreak on adjuvant chemotherapy for patients with stage II or III colon cancer: experiences from a multicentre clinical trial in China","volume":"27","author":"Sun","year":"2020","journal-title":"Curr Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924017167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924017167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T03:34:09Z","timestamp":1733974449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804924017167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":64,"alternative-id":["S0959804924017167"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2024.115109","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2024.115109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115109"}}